Exonate Limited
Exonate is a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases which may lead to vision loss. Our lead asset, EXN407, has the potential to be the first topical treatment for retinal vascular diseases, including diabetic retinopathy and diabetic macular oedema. The asset met all endpoints and displayed encouraging signals of efficacy in diabetic patients with retinal eye disease (diabetic macular oedema) in a Phase Ib/IIa trial.
7-day free trial · no credit card
Verified contacts
11
available on Kipplo
LinkedIn employees
15
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
26
organic / mo
Sign up free to see all 11 verified contacts at Exonate Limited
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
11 contacts with verified email or phone · masked until revealed.
- AM
Amy Murphy
Research Scientist · Science
EmailPhone - CA
Claire Allen
Senior Scientist · Science
EmailPhone - ES
Elizabeth Stewart
Principal Scientist · Science
EmailPhone - SL
Susan Liddell
Senior Scientist · Science
EmailPhone
Showing 4 of 11 verified contacts
Top roles at Exonate Limited
7 distinct titles indexed · top 7 shown.
- 3senior scientist
- 2managing director
- 1chief operating officer
- 1head of biology
- 1medical transcriptionist
- 1principal scientist
- 1research scientist
Sign up to unlock all 11 contacts at Exonate Limited
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 11 verified contacts at Exonate Limited
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.